Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor

por Romaniello, Donatella, Marrocco, Ilaria, Belugali Nataraj, Nishanth, Ferrer, Irene, Drago-Garcia, Diana, Vaknin, Itay, Oren, Roni, Lindzen, Moshit, Ghosh, Soma, Kreitman, Matthew, Kittel, Jeanette Clarissa, Gaborit, Nadege, Bergado Baez, Gretchen, Sanchez, Belinda, Eilam, Raya, Pikarsky, Eli, Paz-Ares, Luis, Yarden, Yosef
Publicado 2020